Table 2.
KEGG pathwaya | Adjusted P-valueb |
---|---|
Drug metabolism—other enzymesM | 1.37 × 10−42 |
Metabolic pathwaysM | 4.58 × 10−23 |
Metabolism of xenobiotics by cytochrome P450M | 6.63 × 10−22 |
Steroid hormone biosynthesisM | 1.73 × 10−21 |
Retinol metabolismM | 9.48 × 10−21 |
Drug metabolism—cytochrome P450M | 5.10 × 10−20 |
Bladder cancerD | 5.21 × 10−17 |
Ascorbate and aldarate metabolismM | 5.21 × 10−17 |
Pentose and glucuronate interconversionsM | 3.73 × 10−16 |
ErbB signaling pathwayE | 1.73 × 10−15 |
Porphyrin and chlorophyll metabolismM | 6.00 × 10−15 |
Other types of O-glycan biosynthesisM | 9.85 × 10−15 |
Bile secretionO | 9.85 × 10−15 |
Starch and sucrose metabolismM | 4.35 × 10−14 |
Pancreatic cancerD | 4.78 × 10−13 |
ABC transportersE | 5.31 × 10−13 |
Pathways in cancerD | 7.13 × 10−12 |
Pyrimidine metabolismM | 9.97 × 10−12 |
Prostate cancerD | 6.39 × 10−9 |
Non-small cell lung cancerD | 9.90 × 10−9 |
GliomaD | 2.94 × 10−9 |
Endometrial cancerD | 3.63 × 10−7 |
Renal cell carcinomaD | 1.55 × 10−6 |
MelanomaD | 1.60 × 10−6 |
Gap junctionC | 4.99 × 10−6 |
Cytokine-cytokine receptor interactionE | 7.82 × 10−6 |
GnRH signaling pathwayO | 8.13 × 10−6 |
Focal adhesionC | 1.65 × 10−5 |
Hepatitis CD | 2.98 × 10−5 |
MAPK signaling pathwayE | 7.00 × 10−4 |
aThe capital letters beside the pathway names are the abbreviation of the KEGG category names at the first-level. C, cell communication, E, environmental information processing, D, human diseases, M, metabolism, O, organismal systems.
bAdjusted P-value was corrected from nominal P-values by Benjamini–Hochberg multiple testing corrections.